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ABSTRACT 
Quantum dots (QDs) are unique probes due to their special properties (brightness, photostability, narrowband emission 
and broadband absorption), and excellent bio(chemical)compatibility for imaging structures and functions of living 
cells. When functionalized with ligands, they enable the recognition of specific targets and the tracking of dynamic 
processes for extended periods of time, detecting biomolecules with a sensitivity extending to the single molecule level. 
Thus, devices and probes based on such nanoparticles are very powerful tools for studying essential processes 
underlying the functions and regulation of living cells. 
 Here we present nanosensors and nanoactuators based on QDs in which the multivalency of these particles plays 
an essential role in the functionality and sensing characteristics of the nanodevices. Two examples are discussed, the 
first being pH nanosensors based on the interplay of the multivalency and energy transfer between the nanoparticles and 
small molecules on their surface, and the second nanoactuators in which a controlled number of molecules of the 
amyloid protein α-synuclein (AS) specifically regulate the aggregation of fluorescently labeled bulk AS protein both in 
vitro and in live cells. 
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1. INTRODUCTION 
Quantum dots (QDs) are exceptional probes due to their unique properties (brightness, photostability, narrowband 
emission and broadband absorption), and capability of broad  spectrum bioconjugation required for the imaging of 
structures and functions in living cells. Complexed to ligands, QDs can recognize specific targets and track them in the 
course of dynamic processes for extended periods of time [1-9]. Due to their facile detection as individual particles, 
QDs offer a sensitivity of detection of biomolecules extending to the single molecule level. Thus, one can study the 
essential processes underlying the functions and regulation of living cells with probes providing the selectivity required 
for dissecting complex networks . 
Characteristics related to the local density and nature of molecular components on the surface of QDs can be 
exploited in cells and tissues for purposes other than mere detection. The systematic “molecular engineering” of the 
surface composition has been a central feature in numerous applications ranging beyond biosensing to cell delivery and 
release and to the activation of individual reactions and entire pathways, as featured in the last section of this report. 
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An essential requirement for the rational design of sensors, effectors and other devices is an understanding of how 
nanomaterials interact with intracellular structures and processes. The level of complexity reflects structural and 
dynamic features necessarily operating in a confined situation. Multivalency is an aspect that has to be considered 
appropriately, inasmuch as its interplay with the photophysical properties of QDs can lead to unique patterns of sensing 
and initiation of activity. 
A widespread tendency is to consider the existence of multiple groups on the surface of NPs as disadvantageous in 
comparison with single attachment or reactive points, the rationale being that extensive conjugation may lead to a 
distribution of NP subpopulations differing in particle-label stoichiometries, to undesirable and nonphysiological cross-
linking, and other effects. Procedures for achieving precise control of the number of sites (down to single moieties) have 
been developed [10]. However, under certain circumstances the presence of a large number of sites may offer distinct 
advantages.  In fact, numerous studies demonstrate that multiple identical or different molecules on the surface of NPs 
can be exploited for a wide variety of purposes, ranging from the control of optical or physical properties to the 
concurrent regulation of different functions.  
Commercially available NPs coated with a polymeric layer to isolate the core-shell structure from the aqueous 
environment have diameters of 15-20 nm and may extend to twice these values if covered with PEG. Is this 
considerable size important such that QDs can be considered to operate more as platforms with a high surface area and 
extensive multivalency rather than as single molecular entities? The answer is probably affirmative, in that size not only 
influences photophysical properties such as quantum confinement but also determines the number of molecules that can 
be attached to the nanoparticle as well as their arrangement on the surface.  
QDs have proven to be very useful as FRET donors and acceptors in numerous applications [11,12]. As donors, QDs 
often are attached to multiple acceptors, thereby achieving efficient quenching of the emission. There have been 
relatively few reports of experiments based on imaging [1,3, 4, 6, 13-17]. In our own studies of cellular signaling 
mediated by growth factors [5, 9, 18-19] and their receptors, QDs conjugated with ligands have revealed the many 
features of binding, endocytosis and intracellular trafficking. In one instance, a biotinylated organic dye FRET acceptor 
served to demonstrate the existence of a novel mechanism for the retrograde transport of activated EGF receptor 
(EGFR) on filopodia, cellular extensions with a core of actin filaments [5].  Figure 1 depicts the strategy for using QDs 
attached to ligands as vehicles for specific targeting of cell surface receptors. In this case, QD-bound biotinylated EGF 
bound efficiently to the EGFR and through this interaction, provided insight into the early stages of internalization of 




Figure 1. Strategy for studying the binding of QD-EGF to the EGF receptor (EGFR) and the resultant activation and 
endocytosis of the receptor into living cells. The image displays A431 cells expressing ERB1-EGFP 20 min after addition of 
biotinylated EGF bound to Streptavidin QD-605. For further details see [9].    
 
 













QD donors have been applied extensively in FRET-based assays of enzymatic activities, with the systematic 
introduction of multifunctionality being a major issue ([20] and references therein). The distance dependence of FRET 
operating via surface-bound or nearby small-molecule acceptors reflects the complex interplay between factors such as 
stoichiometry, spatial distribution and orientation, composition (passivation shell, capping moieties), and shape. (QDs 
emitting at > 600 nm tend to be non-spherical and demonstrate finite emission polarization, [21]).   
Optical properties such as fluorescence intensity or lifetime can also be tailored with FRET acceptors. The design of 
FRET based biosensors for monitoring defined states generally requires control of the number of acceptors associated 




2.1 pH sensors based on commercially available QD donors and multiple pH sensitive small molecule acceptors    
Reversible pH sensors based on QD donors and pH sensitive dyes as acceptors have been recently reported [24]. These 
sensors use a squaraine dye with pKa 8.5 covalenty linked to the nanoparticles, and are evaluated by a ratiometric 
change in fluorescence intensity. 
In our own development of QD-based pH sensors, we sought a system capable of operating over a wide pH range, 
including the physiological cytoplasmic milieu as well as the acidic intracellular compartments characteristic of 
endocytic transport and processing.  We defined further requirements: (i) a sensor based on commercially available 
nanoparticles and pH indicators; and (ii) readout both by steady-state and time resolved spectroscopy (fluorescence 
lifetimes), which in the latter case is largely independent of probe and target concentration and well suited for imaging 
systems. 
The above considerations led us to the choice of Streptavidin-conjugated-ITK-QD605 (Invitrogen) donors and 
biotinylated carboxynaphthofluorescein (bCNF) acceptors (Fig. 2a).  
The choice of a non-covalent pH indicator ligand provides for the systematic  selection of donor/acceptor ratios (and 
thereby dynamic range) and the concurrent conjugation to other biotinylated molecules, such as a growth factor like 
EGF (Fig. 1) for specific targeting of the pH sensor.  The absorption spectra of the acidic and basic forms of the CNF 
indicator (pK 7.65; [24]), compared to the emission spectrum of the QD605, are shown in Fig. 2b. Only the basic form 
of the indicator absorbs well in the emission band of the QD and thus FRET would be expected to operate much more 






 Fig. 2 . Conceptual design of streptavidin-QD605-bCNF pH sensor.   a) schematic representation;  b) QD emission spectrum (z) 
and the two absorption spectra (acidic, ; basic; ) of CNF.  
 
The titration of Streptavidin-ITK-QD605 at pH 10 with bCNF led to significant quenching of the QD donor, 
achieving 80% at approximately 70 equivalents of dye (Fig. 3a). As expected, the emission of QDs loaded with 30 
equivalents of bCNF increased (due to dequenching) as the pH was reduced progressively to pH 4. The two 
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fluorescence lifetimes also increased accordingly, yielding an amplitude-weighted mean value (τmean) between 4 and 9 
ns (Fig. 3b). A remarkable result was the linear dependence of τmean on pH over the wide range of 5.5-9.5, obeying the 





Figure 3.  Dependence of steady-state fluorescence on loading (a) and mean fluorescence lifetime (τmean)  on pH (b).  a) pH 10. 
The control (upper trace) was performed using QD saturated with free biotin prior to the titration. b) i = 30 bCNF/QD. The 
fluorescence lifetimes were measured in an Olympus inverted IX71 microscope to which was attached an LED-based (373 nm) IBH 
(now Horiba Jobin Yvon) TCSPC FluoroCube system. 
 
Another interesting feature of the two fluorescence lifetimes was an increase with pH of the relative amplitude of the 
short component. Numerous potential photophysical models for the system were explored in order to account 
quantitatively for the lifetime data, the dependence of the steady-state QD fluorescence on pH and loading (i 
probes/QD), and an apparent quenching of the bCNF acceptor. A detailed discussion of these issues is outside the scope 
of this report, yet one potential scheme is featured in Figure 4. Two interesting assumptions involve (i) two 
interconverting excited states of the QD, differing in their geometric distribution and thus transfer properties, and the 
reverse transfer of CNF to the QD due to the finite overlap of the CNF emission with the QD absorption. In view of the 
two forms of the CNF populated according to the pH, four evaluations of FRET overlap integrals [25] are required.  
 
Figure 4. Rationale and a photophysical scheme for QD-CNF pH sensor. Left, multiple bCNF acceptors on the surface of 
Streptavidin-ITK-QD605. Right, photophysical model of the system considering both forward (QD (D) → CNF (A) and reverse 
(CNF → QD) FRET, direct excitation of both QD and acceptor, and two virtual excited states of the QD (“peripheral”, S1*, and 
“core”, S2*); the multiple acceptors are depicted as a shell surrounding the QD.  
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Figure 5. Live cell determinations of pH with QD nanosensors. Four equivalents of biotin-EGF and a saturating concentration of 
bCNF were added in sequence to Streptavidin-ITK-QD605. HeLa Cells were incubated with the nanoparticles (a, initial 
determination, t = 0; b, t = 30 min). Intensities are shown at t = 0 and t = 30 min for nanosensors (1) and QD controls (2). Lifetime at 
t = 0 min, corresponded to pH 7.2 (a) and at t = 30 min, to pH 7.2 (b).     
 
Figure 5 shows imaging with the QD nanosensors in living HeLa cells. Lifetime determinations were carried out on the 
signal arising from the complete field selected with a 605 bp emission filter to discriminate for the QD emission. During 
30 min of incubation internalization occurred and was accompanied by an increase of the intensity of emission arising 
from the nanosensors. The pH changes derived from the determination using the calibration curve of Figure 3 
demonstrated a change from pH 7.3 to 7.2 [26]. 
 
2.2 QDs  nanoactuators in amyloid protein aggregation  
Engineering the surface of NPs can also be applied for the initiation and control of the self-assembly of biomolecules. In 
the case of the amyloid-forming proteins involved in most neurodegenerative diseases, such tools can provide important 
insights on the mechanism of fibrillation in living cells and organisms and also have great potential for very sensitive 
readouts in drug discovery efforts. A non-specific approach that takes advantage of the large surface area offered by 
most nanostructures was introduced recently [27].  Co-polymer particles, cerium oxide particles, QDs, and nanotubes 
were tested as nucleation agents for the aggregation of the protein human β2-microglobulin. In the fibrillation process, 
nucleation is a (the?) key rate-determining step. The authors reported that the acceleration of nucleation depended on 
the extent and nature of the particle surface. The disadvantage of this procedure is that it lacks specificity, that is, it 
cannot discriminate between different molecules with the tendency to form aggregates, or molecules exhibiting 
affinities for such structures. In addition, aggregation under such conditions requires high concentrations of the 
nanostructures (100 nM in the case of QDs). Such concentrations can seriously perturb the biological systems under 
study.  
  We have developed an alternative strategy that offers very high specificity and at the time can be applied with very 
low concentration of QDs [28].  By using QDs bearing a controlled number of molecules of α-synuclein (AS) 
molecules, a protein related to the pathogenicity of Parkinson’s disease, it was possible to combine the specific 
detection of aggregation in living cells, with a specific enhancement of the nucleation process triggering fibrillation. 
Saturation of the QDs with AS units, led to the formation of “hot spots” with high nucleation potential, as described 
below. 
Great efforts are devoted to revealing the mechanisms underlying the physiological function(s) of AS and the 
conditions leading to its pathological self-association [29]. In living cells and organisms, oxidative stress conditions can 
be created by exposure to a variety of chemical agents such as FeCl2 or H2O2. These compounds initiate a complex 
cascade of events leading to different disfunctions, including that of amyloid protein aggregation. In the case of the AS-
modified QDs acting as specific nucleation sites, AS aggregation was initiated by a physical-chemical process inherent 
to the NP rather than a consequence of complex mechanisms involving a variety of molecular entities. However, 
external stimulation, such as by oxidative stress, was required in the case of another expression probe we devised [30] 
for AS, an AS mutant (AS-TC) involving a fusion of a 12-aa tag with the tetracysteine motif that specifically binds 
fluorogenic biarsenical compounds (e.g. FlAsH, ReAsH). The functional properties of wild type AS protein were 
retained, such that aggregates, e.g. induced by exposure of cells to Fe++, could be readily detected and characterized 
both in vitro and in live cells [30]. Figure 6 depicts the function of AS-QDs in vitro. The aggregation kinetics were 
monitored in the presence and in the absence of the NPs. The association of QDs with nascent fibers was confirmed by 








AFM (upper panel), and the acceleration of aggregation (shorter lag phase) was demonstrated by the standard 
Thioflavin T (ThioT) assay.  
 
 
Figure 6. QDs acting as specific nucleation sites for α-synuclein (AS)  in vitro. The aggregation of AS was monitored by ThioT 
fluorescence and by AFM. 5 nM (40:1 protein:QD ratio) AS-QDs605 incubated together with 100 mM of AS displayed a shorter lag 
and faster aggregation than in absence of QDs. The upper arrow indicates the aggregation course leading to fibrils attached to NPs, as 
confirmed by AFM (upper panel). The lower arrows show fibril morphologies after aggregation in the absence of the QD nucleation 
centers. Lower panel: aggregation of AS from a natively unstructured protein to oligomers and fibrils. 
 
The combination of this construct with the QD reagents described above was particularly useful, as demonstrated in 
studies of living cells (HeLa, Figure 7). Varying (0-20 nM) concentrations of AS-QDs were microinjected together with 
100 mM of AS-TC.  In the presence of 2 nM QDs (Figure 6, upper panel), cells displayed a markedly increased 
percentage of aggregates, observed 24 h after microinjection, compared to the controls (lower panel) lacking QDs. In 
this strategy, the QDs functioned in a dual manner, i.e. both as biomarkers and “nanoactuators,” i.e. specific nucleation 
agents. As biomarkers at very low concentrations they allowed the facile detection of AS molecules in fibrils, despite 
the presence of a vast excess of monomeric protein. The dual labeling with the biarsenical compounds provided a 
further “photophysical” enhancement of sensitivity [28]. These techniques will also benefit from improved biarsenicals 
that we have synthesized as an associated activity of the above investigations [31]. In addition, we anticipate that dual 
function NPs will undoubtedly be exploited in numerous other systems.  




Figure 7. QDs acting as specific nucleation sites for α-synuclein (AS) in living cells. Cells were microinjected with AS in the 
presence or absence of AS-QDs-605 (40:1 protein:QD) and observed after 24 h of incubation. A mixture 2 nM AS-QDs-605 and 100 
mM of AS-TC labeled with FlAsH was microinjected into HeLa cells (upper panel). QDs were detected, colocalizing to a 
pronounced degree with AS aggregates. Lower panel, microinjection of 100 mM of AS-TC labeled with FlAsH in the absence of 
QDs. 
 
In this report we have emphasized the increasing potential offered by the multivalency derived from introducing 
multiple sites on QDs. Such reagents offer unique opportunities for combining different functions such as sensing, 
targeting, cell penetration and delivery. In addition, by taking advantage of the particular chemistry at the surface of 
NPs, “smart” actuators can de devised and employed. The further combination with programmable inorganic and 
organic materials that demonstrate properties responsive to manipulation of temperature, light, electric and magnetic 
fields, pH, ionic strength will enable a still greater increase in design complexity and utility. A golden age of smart 
nanodevices and nanomachines is in sight. 
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